Tran, Nam K.
Howard, Taylor
Walsh, Ryan
Pepper, John
Loegering, Julia
Phinney, Brett
Salemi, Michelle R.
Rashidi, Hooman H.
Funding for this research was provided by:
SpectraPass, LLC
Article History
Received: 5 January 2021
Accepted: 23 March 2021
First Online: 15 April 2021
Competing interests
: Dr. Tran is a co-inventor the MILO software and co-owner of MILO-ML, LLC. He is also a consultant for Roche Diagnostics and Roche Molecular Systems. Dr. Tran is the Principal Investigator of this SpectraPass, LLC funded study. Dr. Howard is a co-investigator for this SpectraPass, LLC funded study. Dr. Walsh is employed by Shimadzu Scientific Instrumentations who manufacturers the MALDI-TOF-MS instrument used in the study. Mr. Pepper is employed by Allegiant Airlines which collaborators with SpectraPass, LLC. Ms. Loegering is a co-investigator for this SpectraPass, LLC funded study. Dr. Phinney is a co-investigator for this SpectraPass, LLC funded study. Ms. Salemi is a co-investigator for this SpectraPass, LLC funded study. Dr. Rashidi is a co-inventor of MILO, and co-owner of MILO-ML, LLC. He is a co-investigator for this SpectraPass, LLC funded study.